AT
Aprea Therapeutics, Inc.
SEC filingBiotechnology · Doylestown, PA
Amount raised$3.1Msold at filing
Total offering$5.8M$2.7M still open
Investors in the raise8count reported to the SEC
FiledDec 29, 2025first sale Dec 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
John P. HamillExecutive Officer
Jean-Pierre P. BizzariDirector
Gabriela P. GruiaDirector
Rifat B. PamukcuDirector
Bernd B. SeizingerDirector
Marc P. DueyDirector
John B. HennemanDirector
Oren GiladExecutive Officer, Director
Michael P. GrissingerDirector
Richard P. PetersDirector
Executive officers, directors and promoters as listed on the Form D.